Table 2.
Demographic and clinical characteristics of patients with to all eyes, myopic CSC and myopic PNV
| All eyes (N = 15) Mean ± SD |
Myopic CSC (N = 8) Mean ± SD |
Myopic PNV (N = 7) Mean ± SD |
P-value | |
|---|---|---|---|---|
| Age (years) | 50.0 ± 10.5 | 48.9 ± 11.3 | 51.1 ± 9.6 | 0.73 |
| Sex | 1 | |||
| Male/Female, n (%) | 6 (40) / 9 (60) | 3 (37.5) / 5 (62.5) | 3 (42.9) / 4 (57.1) | |
| Follow-up period (months) | 37.3 ± 31.9 | 35 ± 35 | 39.9 ± 28.1 | 0.38 |
| Baseline BCVA, LogMAR | 0.22 ± 0.67 | 0.26 ± 0.76 | 0.18 ± 0.60 | 0.52 |
| Final BCVA, LogMAR | 0.20 ± 0.60 | 0.21 ± 0.62 | 0.19 ± 0.58 | 0.97 |
| Refractive error (Diopter) | −7.8 ± 3.8 | −8.7 ± 4.5 | −6.6 ± 3.2 | 0.49 |
| SFCT (μm) | 104.1 ± 27.4 | 110.1 ± 29.4 | 97.1 ± 25.3 | 0.51 |
CSC Central serous chorioretinopathy, PNV Pachychoroid neovascularization, SD Standard deviation, BCVA Best corrected visual acuity, SFCT Subfoveal choroidal thickness